My PMR journey began in February 2018 on15mg Pred and was smooth apart from one or two bumps in the road. I was diagnosed with asymptomatic large vessel vasculitis in September 2020. My Pred dose for PMR was successfully reduced from 5mg to 2.5mg over three months and I've remained on that dose. After seeing the scan images showing very active inflammation in the aortic arteries in September I reluctantly began 10mg Leflunomide daily five and half months ago and have had no physical symptoms and feel well. I had a telephone appointment a few days ago (after writing to my consultant after the 3-6 month appointment hadn't materialised), not with my consultant but with his research fellow who wants me to reduce Pred as follows:
2.5mg on alternate days for for one month, then 2.5 mg every three days with a face to face review in six months.
Apart from being miffed that it will be a year since diagnosis with no indication of whether the Leflunomide is doing its job and reducing the inflammation, I'm concerned about this method of tapering Pred. I'd appreciate any views on this from anyone and particularly from anyone else on the forum who is taking Leflunomide.